For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
Jewel Jackson, PharmD Candidate
Advertisement
Articles by Jewel Jackson, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
3
Current and Emerging BCMAxCD3 Bispecifics
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5
